Define Ventures, a VC firm based in Silicon Valley, has recently announced the closing of Fund III and Opportunities Fund, raising a total of $460M to fund innovation in healthcare. The firm invests in early-stage digital health startups, including those in incubation, seed, series A, and series B stages. With this new funding, Define Ventures has reached a total of $800M in…
Vice Ventures is a New York-based early stage venture capital fund that aims to deliver superior returns by investing in good companies operating in superficially “bad” industries including alcohol, cannabis, energy, harm-reducing nicotine, psychedelics, sextech, skill-based betting, sports betting, MDMA, and ketamine. The VC firm has now announced the closing of a second $25M fund. Vice Ventures Founding Partner Catharine Dockery started the…
Longevity Venture Partners (LVP), a venture capital firm focused on investing in companies that develop technologies and solutions to support the aging population, has closed a $30M fund. The fund is backed by high net worth individuals and families who share LVP’s commitment to support aging technologies and advancing the field of longevity. LVP will use the funds to invest in early-stage…
Monarch Collective, an investment firm exclusively focused on women’s sports has raised $100 million for its debut fund. The fund was co-founded by Kara Nortman, former partner at Upfron Ventures, who famously launched the Angel Ciry Football Club in 2019, and Jasmine Robinson, former Causeway investor with experience in strategy operations for the San Francisco 49ers. Kara Nortman shares in an interview…
Venture capital firm Amboy Street recently closed its first $20M fund dedicated to investing in sexual wellness and women’s health. The firm is led by an all-female leadership team; a majority of investments will be made into women-led companies. The lack of investment in these spaces has stifled innovation. Amboy Street wants to be a catalyst for change and will back startups…
Investors in the healthcare technology space believe a measurable return on investment (ROI) and clinical validation of the technology’s platform will be the greatest indicators of company success in 2023, according to a new survey of top digital health investors by GSR Ventures. ROI was deemed “important” or “very important” to the success of digital health companies by more than 94% of investor respondents,…
“Just call us America’s sweethearts!” shared the HANX team on Twitter a few weeks ago as they proudly announced their expansion plans and launch in the U.S. The sexual health company, that offers intimate care products like vegan condoms and lube, but also oral contraceptives delivered to your doorstep, was founded in the UK in 2017 and has now made the move…
“Women’s ability to participate freely and fully in the workforce is essential to the growth, performance and resilience of the U.S. economy and the businesses which comprise it. Their participation is contingent upon access to comprehensive reproductive health services, including contraception and abortion. These services are used by nearly all women – 99 percent have used contraception and 25 percent have had…
